11/08/2024
8:33 AM | Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SC 13G | |
11/07/2024
3:22 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:01 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
7:36 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:33 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
7:30 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2024
11:15 PM | Rigel Pharmaceuticals (Filer)
| Form EFFECT | |
|
06/27/2024
3:31 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
7:45 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
6:19 PM | Ali-Jackson Kamil (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:20 PM | HANNAH ALISON L. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:20 PM | Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:20 PM | LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:21 PM | MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:21 PM | Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:06 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:05 PM | Rigel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
7:05 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
4:29 PM | Rigel Pharmaceuticals (Filer)
| Form ARS | |
04/10/2024
3:49 PM | Rigel Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024
3:50 PM | Rigel Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024
4:04 PM | Rigel Pharmaceuticals (Filer)
| Form PRE 14A | |
03/29/2024
3:09 PM | Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:14 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:15 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:15 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:16 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:00 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:30 PM | ARMISTICE CAPITAL, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
11:17 AM | MORGAN STANLEY (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SC 13G | |
02/06/2024
7:18 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:18 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:18 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:34 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
8:56 AM | Rigel Pharmaceuticals (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
01/25/2024
8:16 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
8:17 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
8:17 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
8:17 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:30 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
5:04 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Breaking News: Tesla headed to $500… (Ad) That headline hit late last night…and the rally has begun
Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.  So to claim your free digital copy today, simply follow this link and enter your email address. |
